BRK-B vs MFC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
MFC presents a complex profile with a stable Piotroski F-Score of 4/9 and no Altman Z-Score available for distress analysis. While the stock shows strong long-term price appreciation and a highly attractive PEG ratio (0.78), it is currently trading at a premium to both its Graham Number ($32.43) and Intrinsic Value ($15.75). The severe YoY revenue decline (-34.90%) is a significant concern, though it is offset by a massive Q/Q recovery (+103.98%) and a sustainable dividend profile.
Compare Another Pair
Related Comparisons
BRK-B vs MFC: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Manulife Financial Corporation (MFC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.